Research Article

Serum Kisspeptin and Its Relation to Metabolic Parameters and Glucose Metabolism in Prepubertal and Pubertal Obese Children

Table 1

Clinical characteristics and related parameters of all patients and each subgroup of pubertal status according to HbA1c.

Characteristics/parametersAll (N  = 270)Prepuberty (N  = 26)Puberty (N = 244)
Normal HbA1c (N = 179)Prediabetes HbA1c (N = 91) valueNormal HbA1c (N = 17)Prediabetes HbA1c (N = 9) valueNormal HbA1c (N = 162)Prediabetes HbA1c (N = 82) value

Age (years)12.7 (11.1, 14.5)11.8 (10.7, 12.9)0.00311.0 (10.4, 11.8)10.7 (10.5, 11.7)1.00012.9 (11.3, 14.8)11.9 (10.8, 13.1)0.002
Male/female, N (%)82/97 (46/54)45/46 (49/51)0.57116/1 (94/6)7/2 (78/22)0.26866/96 (41/59)38/44 (46/54)0.403
Weight SDS4.9 (3.2, 6.0)4.4 (3.8, 6.1)0.5332.9 (2.5, 3.9)3.9 (3.2, 5.6)0.0295.0 (3.4, 6.1)4.5 (3.8, 6.3)0.876
Height SDS0.9 (0.1, 1.8)1.3 (0.4, 2.3)0.0390.4 (-0.3, 1.4)1.1 (0.5, 1.5)0.1781.0 (0.1, 1.9)1.3 (0.4, 2.3)0.066
BMI SDS2.6 (2.1, 2.9)2.5 (2.2, 2.9)0.8342.6 (2.3, 2.9)2.6 (2.3, 3.2)0.6092.6 (2.1, 2.9)2.5 (2.1, 2.9)0.917
Waist circumference percentile128 (114, 148)127 (116, 151)0.473115 (101, 120)116 (102, 131)0.293130 (115, 150)129 (118, 151)0.658
Body fat percentage SDS3.3 (2.7, 4.1)3.4 (2.7, 4.0)0.6093.5 (3.3, 3.8)3.6 (3.2, 4.0)0.8413.2 (2.6, 4.1)3.4 (2.6, 4.0)0.642
Kisspeptin (pg/mL)36.7 (29.3, 64.0)51.9 (32.0, 68.4)0.02334.3 (27.4, 50.9)30.8 (28.7, 45.4)0.89337.8 (29.6, 67.5)53.2 (33.9, 69.8)0.015
C-peptide (nmol/L)1.2 (0.9, 1.4)1.3 (1.0, 1.6)0.0210.8 (0.7, 1.3)1.1 (0.7, 1.2)0.5861.2 (0.9, 1.4)1.3 (1.0, 1.7)0.018
HbA1c (%)5.4 (5.2, 5.5)5.9 (5.8, 6.1)<0.0015.4 (5.2, 5.5)5.8 (5.7, 6.0)<0.0015.4 (5.1, 5.5)5.9 (5.8, 6.1)<0.001
Fasting plasma glucose (mmol/L)4.4 (4.3, 4.7)4.6 (4.3, 4.9)0.1534.5 (4.4, 4.7)4.8 (4.6, 5.1)0.0254.4 (4.3, 4.8)4.5 (4.3, 4.8)0.407
1-h plasma glucose (mmol/L)7.4 (6.6, 8.6)8.4 (7.2, 9.8)<0.0017.9 (6.7, 9.5)9.4 (6.8, 10.2)0.3747.4 (6.5, 8.5)8.3 (7.2, 9.7)<0.001
2-h plasma glucose (mmol/L)6.7 (5.7, 7.4)7.3 (6.4, 8.0)0.0017.3 (6.3, 7.6)6.8 (6.3, 7.8)0.9786.7 (5.7, 7.4)7.3 (6.4, 8.0)0.001
AUC glucose (h∙mmol/L)13.9 (12.5, 15.3)14.9 (13.4, 16.9)0.00115.1 (14.0, 17.0)15.8 (13.6, 18.1)0.53513.7 (12.4, 15.2)14.8 (13.2, 16.8)0.001
Fasting plasma insulin (pmol/L)108 (74, 152)120 (89, 207)0.01581 (58, 152)103 (55, 145)0.609110 (75, 152)126 (90, 216)0.015
1-h plasma insulin (pmol/L)820 (566, 1340)1070 (704, 1625)0.019763 (501, 1582)1176 (425, 1715)0.936837 (570, 1311)1063 (726, 1611)0.015
2-h plasma insulin (pmol/L)826 (478, 1361)951 (617, 1688)0.036954 (640, 1340)895 (494, 1320)0.571754 (452, 1374)962 (634, 1717)0.018
AUC insulin (h∙pmol/L)1581 (1031, 2269)1864 (1188, 2785)0.0671678 (1057, 2811)1344 (831, 2778)0.6861571 (1028, 2242)1867 (1220, 2907)0.035
Glucose metabolism status, N (%)
 NGT30 (17)9 (10)3 (18)2 (22)27 (17)7 (8)<0.001
 HI119 (66)45 (49)12 (70)5 (56)0.717107 (66)40 (49)
 AGT30 (17)37 (41)<0.0012 (12)2 (22)28 (17)35 (43)
WBISI2.6 (1.7, 4.0)2.0 (1.2, 3.0)0.0062.4 (1.6, 4.0)2.7 (1.4, 5.5)0.9792.6 (1.7, 4.0)2.0 (1.2, 2.9)0.004
QUICKI0.32 (0.31, 0.34)0.32 (0.29, 0.33)0.0090.34 (0.31, 0.35)0.32 (0.31, 0.37)0.5710.32 (0.31, 0.34)0.31 (0.29, 0.33)0.011
HOMA-IR3.2 (2.0, 4.4)3.7 (2.6, 6.5)0.0092.3 (1.8, 4.1)3.3 (1.6, 4.5)0.5713.2 (2.0, 4.6)3.9 (2.6, 6.8)0.011
IGI2.0 (1.3, 3.2)1.8 (1.3, 3.0)0.4801.5 (1.0, 2.2)1.5 (1.3, 1.8)0.8932.2 (1.3, 3.3)1.8 (1.3, 3.4)0.524
HOMA-β318 (201, 447)316 (222, 527)0.371282 (123, 449)245 (108, 298)0.269318 (209, 450)320 (229, 611)0.172
Total cholesterol (mmol/L)4.5 (4.0, 5.0)4.5 (4.0, 5.0)0.9114.9 (4.3, 5.8)4.8 (4.4, 5.5)0.9144.5 (3.9, 5.0)4.4 (4.0, 4.9)0.997
HDL-C (mmol/L)1.2 (1.0, 1.3)1.1 (1.0, 1.2)0.0421.3 (1.2, 1.4)1.3 (1.1, 1.5)0.6861.1 (1.0, 1.3)1.1 (1.0, 1.2)0.031
LDL-C (mmol/L)2.9 (2.4, 3.4)2.9 (2.5, 3.5)0.6783.1 (2.7, 4.0)3.1 (2.7, 3.5)0.8502.9 (2.3, 3.4)2.9 (2.5, 3.5)0.593
Triglyceride (mmol/L)1.0 (0.7, 1.5)1.1 (0.9, 1.5)0.0930.8 (0.6, 1.4)1.1 (0.8, 1.6)0.3451.0 (0.7, 1.5)1.1 (0.9, 1.5)0.158

AGT, abnormal glucose tolerance; AUC, area under the curve; BMI, body mass index; HbA1c, glycated hemoglobin; HDL-C, high-density lipoprotein cholesterol; HI, normal glucose tolerance with hyperinsulinemia; HOMA-IR, homeostasis model assessment of insulin resistance; HOMA-β, HOMA index; IGI, insulinogenic index; LDL-C, low-density lipoprotein cholesterol; NGT, normal glucose tolerance without hyperinsulinemia; QUICKI, quantitative insulin sensitivity check index; SDS, standard deviation score; WBISI, whole-body insulin sensitivity index. Data are presented as median (IQR); comparing between all children with normal HbA1c and prediabetes HbA1c; comparing between prepubertal children with normal HbA1c and prediabetes HbA1c; and comparing between pubertal children with normal HbA1c and prediabetes HbA1c (Mann–Whitney U test for continuous data and chi-square test for categorical data).